What is NDC 0143-9850?

0143-9850 is the product NDC for Methylprednisolone Sodium Succinate, Methylprednisolone sodium succinate 500 mg/1 injection, powder, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Methylprednisolone Sodium Succinate?

27 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Methylprednisolone Sodium Succinate NDC 0143-9850

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9850Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9850Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9850-01	0014398500100143985001	1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, MULTI-DOSE (0143-9850-01)Marketed from Jan 1, 2016

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methylprednisolone Sodium Succinate
Generic name (nonproprietary): methylprednisolone sodium succinate
Active ingredients: Methylprednisolone sodium succinate — 500 mg/1
Dosage form: Injection, Powder, For solution
Route: Intramuscular, Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202691
Marketing start: Jan 1, 2016
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0143-9850_e073fbeb-1105-4427-a05b-7e12c8f7a33cSPL ID e073fbeb-1105-4427-a05b-7e12c8f7a33cSPL set ID 2e540674-0915-4498-8e2b-751c7e97532aRxCUI 314099UNII LEC9GKY20K
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143985001 followed by a unit qualifier and the quantity

Package 00143-9850-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 13, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of Methylprednisolone Sodium Succinate for Injection, USP, is indicated as follows: Allergic states Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9850

What is NDC 0143-9850?: 0143-9850 is the product NDC for Methylprednisolone Sodium Succinate, Methylprednisolone sodium succinate 500 mg/1 injection, powder, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Methylprednisolone Sodium Succinate.
What is the active ingredient?: Methylprednisolone sodium succinate.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Methylprednisolone Sodium Succinate?: 27 other product NDCs are listed under this name. See all Methylprednisolone Sodium Succinate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Methylprednisolone Sodium Succinate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 40 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	Civica, Inc.	72572-097	72572-0097-25
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 125 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	Civica, Inc.	72572-098	72572-0098-25
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 125 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	REMEDYREPACK INC.	70518-4345	70518-4345-00
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9182	00143-9182-01
Methylprednisolone sodium succinate	Methylprednisolone sodium succinate 125 mg/2mL	InjectionIntramuscular, Intravenous	REMEDYREPACK INC.	70518-3684	70518-3684-00
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 40 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9753	00143-9753-25
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 125 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9754	00143-9754-25
Methylprednisolone sodium succinate	Methylprednisolone sodium succinate 40 mg/mL	InjectionIntramuscular, Intravenous	Dr. Reddy's Laboratories Inc	43598-127	43598-0127-25
Methylprednisolone sodium succinate	Methylprednisolone sodium succinate 1 g/16mL	InjectionIntramuscular, Intravenous	Dr. Reddy's Laboratories Inc	43598-130	43598-0130-74
Methylprednisolone sodium succinate	Methylprednisolone sodium succinate 500 mg/8mL	InjectionIntramuscular, Intravenous	Dr. Reddy's Laboratories Inc	43598-128	43598-0128-11

All 28 Methylprednisolone Sodium Succinate NDCs

Other NDCs under ANDA 202691

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202691
Product	Strength	Form · route	Labeler	Product NDC
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9182
Methylprednisolone Sodium Succinate	Methylprednisolone sodium succinate 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9851